Company: ARTL
Filing Date: 2025-09-04
Form Type: 424B5
Source: 0001640334-25-001624
Chunk: 63

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-09-04
Form: 424B5
Chunk 63
---
3;                                                                                                                       
 our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed with the SEC on May 11, 2023;                                                                                                                      |
|:--|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| · | the portions of our Definitive Proxy Statement on Schedule 14A (other than information furnished rather than filed) that are incorporated by reference into our Annual Report on Form 10‑K, filed with the SEC on May 16, 2023; |
| · | our Current Reports on Form 8-K filed with the SEC on April 21, 2023 and July 3, 2023; and                                                                                                                                      |
| · | The description of our common stock contained in Exhibit 4.1 to our Annual Report on Form 10‑K for the fiscal year ended December 31, 2022 filed with the SEC on March 31, 2023.                                                |

You may request a copy of these filings, at no cost, by writing or telephoning us at the following address:

<div align='center'>Artelo Biosciences, Inc.

505 Lomas Santa Fe, Suite 160

Solana Beach, California 92075

Attn: Investor Relations

(858) 925-7049</div>

| 20 |

<div align='center'>Shares of Common Stock

Pre-Funded Warrants to Purchase up to Shares of Common Stock

______________________________</div>

| PROSPECTUS SUPPLEMENT |

<div align='center'>______________________________

R.F. Lafferty & Co., Inc.

_______________________________

, 2025</div>